ArticleJournal of Cancer2016
AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells.
Sherif Abdelhamed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
78 papers cite itlatest 60 shown
this papercites it